Delivery routes of progesterone in assisted reproduction

References

• Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil. Steril.1(1), 3–25 (1950).
   Web of Science ®Google Scholar
• Noyes RW, Haman JO. Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses. Fertil. Steril.4(6), 504–517 (1953).
   PubMed Web of Science ®Google Scholar
• Natrajan PK, Muldoon TG, Greenblatt RB, Mahesh VB. The effect of progestins on estrogen and progesterone receptors in the human endometrium. J. Reprod. Med.27(4), 227–230 (1982).
   Google Scholar
• Gorodeski IG, Bahari CM, Beery R, Geier A, Lunenfeld B. Effect of single-dose progesterone administration on estradiol receptor levels in normal human endometrium. Gynecol. Obstet. Invest.20(2), 91–95 (1985).
   PubMed Web of Science ®Google Scholar
• Garcia E, Bouchard P, De Brux J et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol. Metab.67(1), 80–87 (1988).
   PubMedGoogle Scholar
• Lessey BA, Killam AP, Metzger DA et al. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J. Clin. Endocrinol. Metab.67(2), 334–340 (1988).
   PubMed Web of Science ®Google Scholar
• Okulicz WC, Ace CI. Temporal regulation of gene expression during the expected window of receptivity in the rhesus monkey endometrium. Biol. Reprod.69(5), 1593–1599 (2003).
   Google Scholar
• Riesewijk A, Martin J, van Os R et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol. Hum. Reprod.9(5), 253–264 (2003).
   PubMed Web of Science ®Google Scholar
• Kao LC, Tulac S, Lobo S et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology143(6), 2119–2138 (2002).
   PubMed Web of Science ®Google Scholar
• Bell SC, Dore-Green F. Detection and characterization of human secretory "pregnancy-associated endometrial α-2-globulin" in uterine luminal fluid. J. Reprod. Immunol.11(1), 13–29 (1987).
   Google Scholar
• Kojima K, Kanzaki H, Iwai M et al. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol. Reprod.50(4), 882–887 (1994).
   PubMed Web of Science ®Google Scholar
• Naresh B, Sengupta J, Bhargava V et al. Immunohistological localisation of vascular endothelial growth factor in human endometrium. Indian J. Physiol. Pharmacol.43(2), 165–170 (1999).
   PubMedGoogle Scholar
• Kimber SJ, Spanswick C. Blastocyst implantation: the adhesion cascade. Semin. Cell Dev. Biol.11(2), 77–92 (2000).
   PubMedGoogle Scholar
• Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science266(5190), 1508–1518 (1994).
   PubMed Web of Science ®Google Scholar
• Paria BC, Lim H, Das SK, Reese J, Dey SK. Molecular signaling in uterine receptivity for implantation. Semin. Cell Dev. Biol.11(2), 67–76 (2000).
   PubMed Web of Science ®Google Scholar
• Navot D, Laufer N, Kopolovic J et al. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N. Engl. J. Med.314(13), 806–811 (1986).
   PubMed Web of Science ®Google Scholar
• Navot D, Anderson TL, Droesch K et al. Hormonal manipulation of endometrial maturation. J. Clin. Endocrinol. Metab.68(4), 801–807 (1989).
   PubMed Web of Science ®Google Scholar
• Navot D, Bergh P. Preparation of the human endometrium for implantation. Ann. NY Acad. Sci.622, 212–219 (1991).
   Google Scholar
• Edwards RG. Human uterine endocrinology and the implantation window. Ann. NY Acad. Sci.541, 445–454 (1988).
   PubMed Web of Science ®Google Scholar
• Damario MA, Lesnick TG, Lessey BA et al. Endometrial markers of uterine receptivity utilizing the donor oocyte model. Hum. Reprod.16(9), 1893–1899 (2001).
   Google Scholar
• Bischof P, Meisser A, Campana A. Mechanisms of endometrial control of trophoblast invasion. J. Reprod. Fertil. Suppl.55, 65–71 (2000).
   PubMedGoogle Scholar
• Zegers-Hochschild F. The normal menstrual cycle. In: Diagnosis and Treatment of Infertility. Rowe PJ,V ikhlyaeva EM (Eds). Hans Huber Publishers, Toronto, Canada, 137–146 (1988).
   Google Scholar
• Gemzell Danielsson K, Swahn ML, Bygdeman M. Effect of antiprogestin, hCG and a prostaglandin analogue on human uterine contractility. Contraception47(3), 295–301 (1993).
   Google Scholar
• Ghosh D, Lalitkumar PG, Wong VJ, Hendrickx AG, Sengupta J. Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey. Hum. Reprod.15(1), 180–188 (2000).
   Google Scholar
• Catalano RD, Yanaihara A, Evans AL et al. The effect of RU486 on the gene expression profile in an endometrial explant model. Mol. Hum. Reprod.9(8), 465–473 (2003).
   PubMed Web of Science ®Google Scholar
• Sauer MV, Paulson RJ, Lobo RA. Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil. Steril.64(1), 111–115 (1995).
   Google Scholar
• Csapo AI, Pulkkinen MO, Ruttner B, Sauvage JP, Wiest WG. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am. J. Obstet. Gynecol.112(8), 1061–1067 (1972).
   PubMed Web of Science ®Google Scholar
• Csapo AI, Pulkkinen MO, Kaihola HL. The effect of estradiol replacement therapy on early pregnant luteectomized patients. Am. J. Obstet. Gynecol.117(7), 987–990 (1973).
   Google Scholar
• Scott R, Navot D, Liu HC, Rosenwaks Z. A human in vivo model for the luteoplacental shift. Fertil. Steril.56(3), 481–484 (1991).
   Google Scholar
• Daya S. Efficacy of progesterone support in the luteal phase following in-vitro fertilization and embryo transfer: meta-analysis of clinical trials. Hum. Reprod.3(6), 731–734 (1988).
   PubMed Web of Science ®Google Scholar
• Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil. Steril.61(6), 1068–1076 (1994).
   PubMed Web of Science ®Google Scholar
• Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum. Reprod.17(9), 2287–2299 (2002).
   PubMed Web of Science ®Google Scholar
• Nosarka S, Kruger T, Siebert I, Grove D. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol. Obstet. Invest.60(2), 67–74 (2005).
   PubMed Web of Science ®Google Scholar
• Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst. Rev.3, CD004830 (2004).
   Google Scholar
• Beckers NG, Macklon NS, Eijkemans MJ et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J. Clin. Endocrinol. Metab.88(9), 4186–4192 (2003).
   PubMed Web of Science ®Google Scholar
• Kolb BA, Najmabadi S, Paulson RJ. Ultrastructural characteristics of the luteal phase endometrium in patients undergoing controlled ovarian hyperstimulation. Fertil. Steril.67(4), 625–630 (1997).
   PubMed Web of Science ®Google Scholar
• Fanchin R, Righini C, de Ziegler D et al. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil. Steril.75(6), 1136–1140 (2001).
   PubMed Web of Science ®Google Scholar
• Fanchin R, Righini C, Olivennes F et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum. Reprod.13(7), 1968–1974 (1998).
   PubMed Web of Science ®Google Scholar
• Lyons EA, Taylor PJ, Zheng XH et al. Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women. Fertil. Steril.55(4), 771–774 (1991).
   PubMed Web of Science ®Google Scholar
• Nyboe Andersen A, Popovic-Todorovic B, Schmidt KT et al. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum. Reprod.17(2), 357–361 (2002).
   PubMed Web of Science ®Google Scholar
• Lobo RA. Proceedings of the Consensus Development Conference on Progestagen. Worldwide Medical Group, NY, USA (1989).
   Google Scholar
• Sitruk-Ware R. Estrogen and progestogens – different routes of administration. Climacteric8(Suppl. 1), 1–2 (2005).
   PubMed Web of Science ®Google Scholar
• Arafat ES, Hargrove JT, Maxson WS et al. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am. J. Obstet. Gynecol.159(5), 1203–1209 (1988).
   PubMed Web of Science ®Google Scholar
• Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric8(Suppl. 1), 3–63 (2005).
   PubMed Web of Science ®Google Scholar
• Levine H, Watson N. Comparison of the pharmacokinetics of crinone 8% administered vaginally versus prometrium administered orally in postmenopausal women (3). Fertil. Steril.73(3), 516–521 (2000).
   PubMed Web of Science ®Google Scholar
• Nahoul K, Dehennin L, Jondet M, Roger M. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas16(3), 185–202 (1993).
   PubMed Web of Science ®Google Scholar
• Ottoson UB, Carlstrom K, Damber JE, von Schoultz B. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration. Br. J. Obstet. Gynaecol.91(11), 1111–1119 (1984).
   PubMedGoogle Scholar
• Bulletti C, de Ziegler D, Flamigni C et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum. Reprod.12(5), 1073–1079 (1997).
   PubMed Web of Science ®Google Scholar
• Cicinelli E, De Ziegler D, Morgese S et al. "First uterine pass effect" is observed when estradiol is placed in the upper but not lower third of the vagina. Fertil. Steril.81(5), 1414–1416 (2004).
   PubMed Web of Science ®Google Scholar
• Miles RA, Paulson RJ, Lobo RA et al. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil. Steril.62(3), 485–490 (1994).
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Balmaceda JP, Fabres C et al. Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. Hum. Reprod.15(10), 2093–2097 (2000).
   PubMed Web of Science ®Google Scholar
• Ragni G, Piloni S, Rossi P et al. Endometrial morphology and ultrasound vascular findings. A randomized trial after intramuscular and vaginal progesterone supplementation in IVF. Gynecol. Obstet. Invest.47(3), 151–156 (1999).
   Google Scholar
• Bourgain C, Smitz J, Camus M et al. Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles. Hum. Reprod.9(1), 32–40 (1994).
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Croxatto HB, Alam V. Endometrial histology and progesterone concentration in women with ovarian failure supplemented with a progesterone vaginal ring. Report on six pregnancy cycles after oocyte donation. Hum. Reprod.11(Abstract Book 1), 53 (1996).
   PubMed Web of Science ®Google Scholar
• Penzias AS. Luteal phase support. Fertil. Steril.77(2), 318–323 (2002).
   PubMed Web of Science ®Google Scholar
• Licciardi FL, Kwiatkowski A, Noyes NL et al. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil. Steril.71(4), 614–618 (1999).
   PubMed Web of Science ®Google Scholar
• Pouly JL, Bassil S, Frydman R et al. Luteal support after in-vitro fertilization: crinone 8%, a sustained release vaginal progesterone gel, versus utrogestan, an oral micronized progesterone. Hum. Reprod.11(10), 2085–2089 (1996).
   Google Scholar
• Saucedo LLE, Hernandez AS, Santos HR, Arenas MI, Patrizio P. Randomized trial of three diferent forms of progesterone supplementation in ART: preliminary results (abstract). Fertil. Steril.74(Suppl. 1), S150 (2000).
   Google Scholar
• Bourgain C, Devroey P, Van Waesberghe L, Smitz J, Van Steirteghem AC. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum. Reprod.5(5), 537–543 (1990).
   PubMed Web of Science ®Google Scholar
• Unfer V, Casini ML, Costabile L et al. 1 7 α-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. Reprod. Biomed. Online9(1), 17–21 (2004).
   PubMed Web of Science ®Google Scholar
• Costabile L, Gerli S, Manna C et al. A prospective randomized study comparing intramuscular progesterone and 17α-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil. Steril.76(2), 394–396 (2001).
   Google Scholar
• Chantilis SJ, Zeitoun KM, Patel SI et al. Use of crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil. Steril.72(5), 823–829 (1999).
   PubMedGoogle Scholar
• Schoolcraft WB, Hesla JS, Gee MJ. Experience with progesterone gel for luteal support in a highly successful IVF programme. Hum. Reprod.15(6), 1284–1288 (2000).
   PubMed Web of Science ®Google Scholar
• Damario MA, Goudas VT, Session DR, Hammitt DG, Dumesic DA. Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer. Fertil. Steril.72(5), 830–836 (1999).
   Google Scholar
• Abate A, Perino M, Abate FG et al. Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study. Clin. Exp. Obstet. Gynecol.26(3–4), 203–206 (1999).
   PubMedGoogle Scholar
• Devroey P, Palermo G, Bourgain C et al. Progesterone administration in patients with absent ovaries. Int. J. Fertil.34(3), 188–193 (1989).
   PubMedGoogle Scholar
• Smitz J, Devroey P, Faguer B et al. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum. Reprod.7(2), 168–175 (1992).
   PubMed Web of Science ®Google Scholar
• Lightman A, Kol S, Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Hum. Reprod.14(10), 2596–2599 (1999).
   PubMedGoogle Scholar
• Roman E, Aytoz A, Smitz, JE et al. Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. Hum. Reprod.15(7), 1435–1439 (2000).
   Google Scholar
• Kleinstein J. Efficacy and tolerability of vaginal progesterone capsules (utrogest 200) compared with progesterone gel (crinone 8%) for luteal phase support during assisted reproduction. Fertil. Steril.83(6), 1641–1649 (2005).
   PubMed Web of Science ®Google Scholar
• Germond M, Capelli P, Bruno G et al. Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization. Fertil. Steril.77(2), 313–317 (2002).
   Google Scholar
• Ludwig M, Schwartz P, Babahan B et al. Luteal phase support using either crinone 8% or utrogest: results of a prospective, randomized study. Eur. J. Obstet. Gynecol. Reprod. Biol.103(1), 48–52 (2002).
   PubMed Web of Science ®Google Scholar
• Friedler JS, Raziel A, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. Hum. Reprod.14(8), 1944–1948 (1999).
   PubMed Web of Science ®Google Scholar
• Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J. Steroid Biochem. Mol. Biol.97(5), 416–420 (2005).
   PubMed Web of Science ®Google Scholar